1 Neoadjuvant Chemotherapy Reduces Colon Cancer Recurrence Rate By 28%, With Fewer Post-Operative Complications, Study Shows Jul 07, 2025
Read More Apparatus World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us Jul 06, 2025
Read More Medical Neoadjuvant Chemotherapy Reduces Colon Cancer Recurrence Rate By 28%, With Fewer Post-Operative Complications, Study Shows Jul 07, 2025
Read More Medical More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Jul 08, 2025
Read More Apparatus Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For Jul 01, 2025
